Skip to main content
Signal8

Petros Pharmaceuticals, Inc. (PTPI) Form 8-K — Jun 5, 2026

$PTPIForm 8-KItems 5.02Filed Jun 5, 2026, 5:00 PM ET0001104659-26-071027Original filing

Petros Pharmaceuticals granted 7 million restricted shares to its Chairman, two directors, and its President/CCO on June 5, 2026. These awards were issued outside of the company’s existing Amended and Restated 2020 Omnibus Incentive Compensation Plan. The grants include 4.375 million shares to Chairman Joshua Silverman, 1.875 million to Director Bruce Bernstein, and 375,000 each to President Fady Boctor and Director Wayne Walker. Fifty percent of each award vested immediately, with the remainder vesting after six months contingent on continued service.

Key figures

Shares Offered
7000000
Shares to Boctor
375000
Shares to Walker
375000
Vesting schedule
50% on Grant Date, 50% on 6-month anniversary
Shares to Bernstein
1875000
Shares to Silverman
4375000

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.